Besides aging and inflammation inducing endothelial dysfunction, the deficiency of protease-activated receptor 2 (PAR2) is associated with extracellular matrix remodeling, which might be an alternative contributor to HFpEF pathophysiology (112). This evidence concerns the gene F2RL1 and endothelial dysfunction.